Clinical Trials in Anniston, Alabama

Find clinical trials in Anniston, Alabama. Discover local research opportunities and treatment options in your area.

30 Active Trials Found in Anniston

Showing 30 trials on this page

Page 2 of 2

A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

NCT ID: NCT06965413

This clinical trial is studying a new treatment for adults who are overweight or have obesity, especially those who also have weight-related health issues like high blood pressure or sleep apnea. T...

Recruiting

Phase: PHASE2 Conditions: Obesity, Overweight +1 more

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

NCT ID: NCT06643728

This clinical trial is exploring the effectiveness and safety of two medications, Bimagrumab and Tirzepatide, for helping adults with obesity or who are overweight manage their weight. The study is...

Recruiting

Phase: PHASE2 Conditions: Obesity, Overweight

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT ID: NCT06382311

This clinical trial is studying a new mRNA vaccine designed to protect against the H5N1 influenza virus, commonly known as bird flu. The goal is to find the right dose of the vaccine and to assess ...

Recruiting

Phase: PHASE1 Conditions: Influenza, Human

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

NCT ID: NCT06742281

This clinical trial is studying a new COVID-19 vaccine called CVXGA, which is delivered as a nasal spray. The goal is to see how safe and effective this vaccine is compared to a well-known vaccine ...

Recruiting

Phase: PHASE2 Conditions: COVID-19

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT ID: NCT05831111

This clinical trial is studying a new candidate vaccine called mRNA-1195, which is designed to help protect against Epstein-Barr Virus (EBV) infection. The main goal of the study is to check how sa...

Recruiting

Phase: PHASE1 Conditions: Epstein-Barr Virus Infection

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss

NCT ID: NCT06299098

This clinical trial is studying whether two experimental drugs, trevogrumab and garetosmab, are safe and effective for weight loss when combined with a well-known medication called semaglutide (Weg...

Recruiting

Phase: PHASE2 Conditions: Obesity

Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

NCT ID: NCT04955795

This clinical trial is looking at how effective a combination of two types of treatments can be for individuals living with HIV who have unhealthy alcohol use. Specifically, the study will compare ...

Recruiting

Phase: NA Conditions: Hiv, Alcohol Problem

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT ID: NCT05488340

The ELIMINATE Trial is a clinical study investigating a new treatment called LBP-EC01 for women who have acute urinary tract infections (UTIs) caused by a drug-resistant bacterium called E. coli. T...

Recruiting

Phase: PHASE2 Conditions: Urinary Tract Infections

ConsideRAte Study - Splenic Stimulation for RA

NCT ID: NCT05003310

The ConsideRAte Study is researching a new treatment for people with rheumatoid arthritis (RA) who have not found relief from standard medications. This study will explore the safety and effects of...

Recruiting

Phase: NA Conditions: Rheumatoid Arthritis

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT ID: NCT04849728

This clinical trial, called NATiV3, is studying a new treatment called lanifibranor for adults with a liver condition known as Nonalcoholic Steatohepatitis (NASH) and fibrosis stages F2 or F3. NASH...

Recruiting

Phase: PHASE3 Conditions: NASH - Nonalcoholic Steatohepatitis

Search All Trials Browse All Locations